Table 2.
Eight most frequently used chemotherapy drugs with evaluable responses
| Drug | n | CR | PR | SD | PD | ORR (%) | RR (%) | Median duration of response | Median time to progression |
|---|---|---|---|---|---|---|---|---|---|
| Etoposide | 54 | 0 | 3 | 18 | 33 | 5.6 | 38.9 | 0 (CI 0; 5.04) | 3.54 (CI 1.64; 12.45) |
| Temozolomide | 46 | 1 | 3 | 9 | 33 | 8.7 | 28.3 | 0 (CI 0; 0.79) | 2.64 (CI 1.59; 8.09) |
| Trofosfamide | 30 | 0 | 1 | 10 | 19 | 3.3 | 36.7 | 0 (CI 0; 6.13) | 4 (CI 1.81; 11.44) |
| Carboplatin | 20 | 0 | 1 | 7 | 12 | 5 | 40 | 0 (CI 0; 4.69) | 3.93 (CI 1.71; 12.87) |
| Cyclophosphamide | 13 | 0 | 0 | 5 | 8 | 0 | 38.5 | 0 (CI 0; 2.24) | 3.17 (CI 1.93; 8.97) |
| Vincristine | 12 | 0 | 0 | 4 | 8 | 0 | 33.3 | 0 (CI 0; 2.64) | 3.29 (CI 2.2; 7.46) |
| Sirolimus | 8 | 0 | 0 | 4 | 4 | 0 | 50 | 1.28 (CI 0; 5.95) | 11.51 (CI 4.22; 14) |
| Topotecan | 7 | 0 | 0 | 0 | 7 | 0 | 0 | 0 (CI 0; 0) | 1.32 (CI 0.55; 1.61) |
n Number of times used, CR complete remission, PR partial remission, SD disease stabilization, PD progressive disease, ORR objective response-rate, RR response-rate, CI 95% confidence-interval